Frauenklinik

Adresse:
Universitätsstraße 21/23
91054 Erlangen



Untergeordnete Organisationseinheiten

Lehrstuhl für Geburtshilfe und Frauenheilkunde


Publikationen (Download BibTeX)

Go to first page Go to previous page 1 von 12 Go to next page Go to last page

Mavaddat, N., Michailidou, K., Dennis, J., Lush, M., Fachal, L., Lee, A.,... Easton, D.F. (2019). Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes. American Journal of Human Genetics, 104(1), 21-34. https://dx.doi.org/10.1016/j.ajhg.2018.11.002
Krebs, J., Wasner, S., Egloffstein, S., Lux, M.P., Morawa, E., Beckmann, M., & Erim, Y. (2018). Resilience, Fear of Progression and Psychosocial Distress in Patients with Breast Cancer and Gynecological Tumors Seeking a Second Opinion. Psychotherapie Psychosomatik Medizinische Psychologie. https://dx.doi.org/10.1055/a-0668-1206
Kelemen, L.E., Earp, M., Fridley, B.L., Chenevix-Trench, G., Fasching, P.A., Beckmann, M.,... Berchuck, A. (2018). rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology. International Journal of Molecular Sciences, 19(9). https://dx.doi.org/10.3390/ijms19092473
Schmid, R., Wolf, K., Robering, J.W., Strauss, S., Strissel, P., Strick, R.,... Weigand, A. (2018). ADSCs and adipocytes are the main producers in the autotaxin-lysophosphatidic acid axis of breast cancer and healthy mammary tissue in vitro. Bmc Cancer, 18(1). https://dx.doi.org/10.1186/s12885-018-5166-z
Erber, R., Hartmann, A., Beckmann, M., Mackensen, A., Kremer, A., Reimann, H.,... Fasching, P.A. (2018). TILGen study-immunological targets in patients with breast cancer : Influence of tumor-infiltrating lymphocytes. Pathologe, 39(Suppl 2), 236-240. https://dx.doi.org/10.1007/s00292-018-0526-7
Gaß, P., Lux, M.P., Rauh, C., Hein, A., Bani, M., Fiessler, C.,... Wunderle, M. (2018). Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer. Bmc Cancer, 18(1). https://dx.doi.org/10.1186/s12885-018-4925-1
Gebrekidan, M., Erber, R., Hartmann, A., Fasching, P.A., Emons, J., Beckmann, M., & Bräuer, A. (2018). Breast Tumor Analysis Using Shifted-Excitation Raman Difference Spectroscopy (SERDS). Technology in Cancer Research & Treatment, 17. https://dx.doi.org/10.1177/1533033818782532
Brennan, M., Gaß, P., Häberle, L., Wang, D., Hartmann, A., Lux, M.P.,... Fasching, P.A. (2018). The effect of participation in neoadjuvant clinical trials on outcomes in patients with early breast cancer. Breast Cancer Research and Treatment, 171(3), 747-758. https://dx.doi.org/10.1007/s10549-018-4829-4
Gaß, P., Untch, M., Mueller, V., Moebus, V., Thomssen, C., Häberle, L.,... Nabieva, N. (2018). Using Probability for Pathological Complete Response (pCR) as a Decision Support Marker for Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Patients - a Survey Among Physicians. Geburtshilfe und Frauenheilkunde, 78(7), 707-714. https://dx.doi.org/10.1055/a-0642-9462
Hoyer, J., Vasileiou, G., Uebe, S., Wunderle, M., Kraus, C., Fasching, P.A.,... Reis, A. (2018). Addition of triple negativity of breast cancer as an indicator for germline mutations in predisposing genes increases sensitivity of clinical selection criteria. Bmc Cancer, 18(1). https://dx.doi.org/10.1186/s12885-018-4821-8
Schlichtig, K., Lechner, P., Grafe, C., Ferstl, B., Fuchs, F., Hein, A.,... Dorje, F. (2018). Medication safety in patients treated with new oral antitumor agents: A prospective, randomized investigation on the impact of intensified clinical pharmaceutical/clinical pharmacological care on patient safety, patient knowledge and patient well-being (AMBORA). Supported by the German Cancer Aid within the Comprehensive Cancer Center Erlangen-EMN. (pp. 198-198).
Emons, J., Wunderle, M., Hartmann, A., Radicke, M., Rauh, C., Uder, M.,... Jud, S. (2018). Initial clinical results with a fusion prototype for mammography and three-dimensional ultrasound with a standard mammography system and a standard ultrasound probe. Acta Radiologica, 59(12), 1406-1413. https://dx.doi.org/10.1177/0284185118762249
Würfel, F., Erber, R., Hübner, H., Hein, A., Lux, M.P., Jud, S.,... Rübner, M. (2018). TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients - First Results on the Influence of Tumor-Infiltrating Lymphocytes. Breast Care, 13(1), 8-14.
Wunderle, M., Gaß, P., Häberle, L., Flesch, V.M., Rauh, C., Bani, M.,... Hein, A. (2018). BRCA mutations and their influence on pathological complete response and prognosis in a clinical cohort of neoadjuvantly treated breast cancer patients. Breast Cancer Research and Treatment, 171(1), 85-94. https://dx.doi.org/10.1007/s10549-018-4797-8
Siegler, L., Erber, R., Burghaus, S., Brodkorb, T., Wachter, D., Wilkinson, N.,... Agaimy, A. (2018). Fumarate hydratase (FH) deficiency in uterine leiomyomas: recognition by histological features versus blind immunoscreening. Virchows Archiv. https://dx.doi.org/10.1007/s00428-018-2292-6
Painter, J.N., O'Mara, T.A., Morris, A.P., Cheng, T.H.T., Gorman, M., Martin, L.,... Spurdle, A.B. (2018). Genetic overlap between endometriosis and endometrial cancer: evidence from cross-disease genetic correlation and GWAS meta-analyses. Cancer Medicine, 7(5), 1978-1987. https://dx.doi.org/10.1002/cam4.1445
O'Mara, T.A., Glubb, D.M., Amant, F., Annibali, D., Ashton, K., Attia, J.,... Thompson, D.J. (2018). Identification of nine new susceptibility loci for endometrial cancer. Nature Communications, 9(1). https://dx.doi.org/10.1038/s41467-018-05427-7
Heger, L., Balk, S., Lühr, J., Heidkamp, G., Lehmann, C., Hatscher, L.,... Dudziak, D. (2018). CLEC10A Is a Specific Marker for Human CD1c+ Dendritic Cells and Enhances Their Toll-Like Receptor 7/8-Induced Cytokine Secretion. Frontiers in Immunology, 9. https://dx.doi.org/10.3389/fimmu.2018.00744
Huebner, H., Knoerr, B., Betzler, A., Hartner, A., Kehl, S., Baier, F.,... Rübner, M. (2018). Detyrosinated tubulin is decreased in fetal vessels of preeclampsia placentas. Placenta, 62, 58-65. https://dx.doi.org/10.1016/j.placenta.2017.12.019
Poehls, U.G., Hack, C., Ekici, A.B., Beckmann, M., Fasching, P.A., Rübner, M., & Hübner, H. (2018). Saliva samples as a source of DNA for high throughput genotyping: an acceptable and sufficient means in improvement of risk estimation throughout mammographic diagnostics. European Journal of Medical Research, 23(1). https://dx.doi.org/10.1186/s40001-018-0318-9


Zusätzliche Publikationen (Download BibTeX)


Emons, G., Kurzeder, C., Schmalfeldt, B., Neuser, P., De Gregorio, N., Pfisterer, J.,... Hilpert, F. (2016). Temsirolimus in women with platinum-refractory/resistant ovarian cancer or advanced/recurrent endometrial carcinoma. A phase II study of the AGO-study group (AGO-GYN8). Gynecologic Oncology, 140(3), 450-6. https://dx.doi.org/10.1016/j.ygyno.2015.12.025
Gabriel, L., Lermann, J., Schott, S., & Puppe, J. (2016). Help Shape Training. Geburtshilfe und Frauenheilkunde, 76(4), 323-324. https://dx.doi.org/10.1055/s-0042-105014

Zuletzt aktualisiert 2016-05-05 um 04:59